Why the study?
Conventional medical imaging modalities for arterial stiffness measurement are non-scalable and unviable for field-level screening, leaving an unmet need for affordable, easy-to-operate automated non-invasive technologies.
Does the ARTSENS® Pen provide comparable carotid stiffness measurements to a clinical-grade B-mode ultrasound system in human subjects?
Does the ARTSENS® Pen provide comparable carotid stiffness measurements to a clinical-grade B-mode ultrasound system in human subjects?
The ARTSENS® Pen is a valid, portable, and easy-to-use alternative to conventional ultrasound for measuring carotid stiffness, making it suitable for field-level cardiovascular risk screening.
Supports ARTSENS® Pen comparability; leaves open prospective validation before clinical adoption.
Objective : The conventional medical imaging modalities used for arterial stiffness measurement are non-scalable and unviable for field-level vascular screening. The need for an affordable, easy-to-operate automated non-invasive technologies remains unmet. To address this need, we present a portable image-free ultrasound device—ARTSENS ® Pen, that uses a single-element ultrasound transducer for carotid stiffness evaluation. Approach: The performance of the device was clinically validated on a cohort of 523 subjects. A clinical-grade B-mode ultrasound imaging system (ALOKA eTracking) was used as the reference. Carotid stiffness measurements were taken using the ARTSENS ® Pen in sitting posture emulating field scenarios. Main results: A statistically significant correlation (r > 0.80, p < 0.0001) with a non-significant bias was observed between the measurements obtained from the two devices. The ARTSENS ® Pen device could perform highly repeatable measurements (with variation smaller than 10%) on a relatively larger percentage of the population when compared to the ALOKA system. The study results also revealed the sensitivity of ARTSENS ® Pen to detect changes in arterial stiffness with age. Significance: The easy-to-use technology and the automated algorithms of the ARTSENS ® Pen make it suitable for cardiovascular risk assessment in resource-constrained settings.
No takes yet. Share an insight, caveat, or question.
Joseph et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: